TYPE OF TREATMENT FACILITY IMPACTS SURVIVAL OF PATIENTS WITH OVARIAN CLEAR CELL CARCINOMA

被引：0
|
作者：
Nasioudis, D. [1 ]
Haggerty, A. [1 ]
Giuntoli, R., II [1 ]
Burger, R. [1 ]
Morgan, M. [1 ]
Ko, E. [1 ]
Latif, N. [1 ]
机构：
[1] Univ Penn Hlth Syst, Div Gynecol Oncol, Philadelphia, PA USA
来源：
INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER | 2018年 / 28卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
IGCS8-0371
引用
收藏
页码：787 / 787
页数：1
相关论文
共 50 条
  • [31] Is the presence of endometriosis associated with a survival benefit in pure ovarian clear cell carcinoma?
    Sahin, Hanifi
    Sari, Mustafa Erkan
    Cuylan, Zeliha Firat
    Haberal, Asuman Nihan
    Sirvan, Levent
    Coban, Gonca
    Yalcin, Ibrahim
    Gungor, Tayfun
    Celik, Husnu
    Meydanli, Mehmet Mutlu
    Ayhan, Ali
    ARCHIVES OF GYNECOLOGY AND OBSTETRICS, 2018, 297 (04) : 1005 - 1013
  • [32] The proteome of clear cell ovarian carcinoma
    Ji, Jennifer X.
    Cochrane, Dawn R.
    Negri, Gian Luca
    Colborne, Shane
    Miko, Sandra E. Spencer
    Hoang, Lynn N.
    Farnell, David
    Tessier-Cloutier, Basile
    Huvila, Jutta
    Thompson, Emily
    Leung, Samuel
    Chiu, Derek
    Chow, Christine
    Ta, Monica
    Kobel, Martin
    Feil, Lucas
    Anglesio, Michael
    Goode, Ellen L.
    Bolton, Kelly
    Morin, Gregg B.
    Huntsman, David G.
    JOURNAL OF PATHOLOGY, 2022, 258 (04): : 325 - 338
  • [33] Rethinking of treatment strategies and clinical management in ovarian clear cell carcinoma
    Kazuaki Takahashi
    Masataka Takenaka
    Ayako Kawabata
    Nozomu Yanaihara
    Aikou Okamoto
    International Journal of Clinical Oncology, 2020, 25 : 425 - 431
  • [34] Specific issues in the systemic treatment strategy for ovarian clear cell carcinoma
    Kfoury, M.
    Tan, D.
    ESMO OPEN, 2024, 9 (04)
  • [35] Rethinking of treatment strategies and clinical management in ovarian clear cell carcinoma
    Takahashi, Kazuaki
    Takenaka, Masataka
    Kawabata, Ayako
    Yanaihara, Nozomu
    Okamoto, Aikou
    INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY, 2020, 25 (03) : 425 - 431
  • [36] Ovarian clear cell carcinoma: open questions on the management and treatment algorithm
    Rosso, Roberta
    Turinetto, Margherita
    Borella, Fulvio
    Chopin, Nicolas
    Meeus, Pierre
    Laine, Alexandra
    Ray-Coquard, Isabelle
    Le Saux, Olivia
    Ferraioli, Domenico
    ONCOLOGIST, 2025, 30 (01):
  • [37] The impact of chemotherapy on survival in uterine clear cell carcinoma patients
    Rauh-Hain, J. Alejandro
    Gockley, Allison
    Clemmer, Joel
    Clark, Rachel M.
    Hall, Tracilyn
    Growdon, Whitfield
    Goodman, A. K.
    Boruta, David, II
    Schorge, John
    del Carman, Marcela
    GYNECOLOGIC ONCOLOGY, 2015, 136 (02) : 407 - 408
  • [38] Survival probability in ovarian clear cell adenocarcinoma
    Kennedy, AW
    Markman, M
    Biscotti, CV
    Emery, JD
    Rybicki, LA
    GYNECOLOGIC ONCOLOGY, 1999, 74 (01) : 108 - 114
  • [39] PATIENTS WITH OVARIAN CLEAR CELL CARCINOMA ARE AT HIGH RISK OF SECONDARY MALIGNANCY
    Nguyen, J. M. V.
    Vicus, D.
    Bernardini, M. Q.
    Hogen, L.
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2019, 29 : A130 - A131
  • [40] CYTOLOGIC FINDINGS OF ASCITES IN PATIENTS WITH OVARIAN CLEAR CELL-CARCINOMA
    NISHIDA, M
    KANEKO, M
    YOSHIDA, T
    ACTA CYTOLOGICA, 1981, 25 (01) : 52 - 52
12345